Summary
- Genetic testing company 23andMe is filing for Chapter 11 bankruptcy in a bid to sell the business after years of financial difficulties.
- The firm has suffered a plummet in value from 6bnafterits2021flotationtoareported50m following difficulties turning a profit.
- It recently announced job cuts of 40% as well as settling a lawsuit for $30m for failing to protect customer data.
- Former CEO Anne Wojcicki will step down and bid for the company independently, with CFO Joe Selsavage taking on the CEO role on an interim basis.
- 23andMe has said operations will continue as normal during the sale process, and customers’ data and subscriptions won’t be affected.
By Jess Weatherbed
Original Article